Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 5Phase 1 4Phase 3 1

Status

Unknown 2Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 35Other hematologic neoplasm 30Thoracic 23Breast 22Gynecologic 13Other solid neoplasm 12Myeloid 12Genitourinary 11Head & Neck 10Sarcoma 9Lymphoid 9Plasma cell 7Endocrine 6Dermatologic 5CNS 4Tumor-Agnostic 3Other 3NET 3Classical hematology 1

Conditions

Melanoma 4Sarcoma 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 114Ipilimumab 114pembrolizumab 108aldesleukin 76Cyclophosphamide 70fludarabine phosphate 51Interleukin-2 48Temozolomide 41Dacarbazine 36trametinib 33dabrafenib 30Bevacizumab 30sargramostim 29Radiotherapy 29incomplete Freund's adjuvant 27fludarabine 27Vemurafenib 25Radiosurgery 25Carboplatin 25Paclitaxel 23binimetinib 22Biopsy 22CTLA-4 Antigen 21Peripheral Blood Stem Cell Transplantation 20encorafenib 19cemiplimab 19atezolizumab 19HhAntag691 19Mycophenolic Acid 18Aminolevulinic Acid 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Injections × Dermatologic × Clear all
NCT04722575 2025-03-13

NEO-TIM

Fondazione Melanoma Onlus

Phase 2 Active not recruiting
95 enrolled
Dermatologic

Melanoma

NCT06500091 2024-07-15

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting
54 enrolled
DermatologicSarcoma

Melanoma, Sarcoma

NCT04669808 2024-03-18

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma

Sirnaomics

Phase 2 Completed
32 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT05135715 2024-02-20

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

RemeGen Co., Ltd.

Phase 2 Unknown
50 enrolled
Dermatologic

Melanoma

NCT04593485 2020-12-23

Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract

Fudan University

Phase 2 Unknown
40 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡